These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19005759)

  • 21. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease.
    Aller R; De Luis DA; Fernandez L; Calle F; Velayos B; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez JM
    Eur Rev Med Pharmacol Sci; 2009; 13(5):357-64. PubMed ID: 19961041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
    Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B
    Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Visfatin in obese patients, relation with cardiovascular risk factors, a cross sectional study].
    de Luis DA; Ballesteros M; Ruiz E; Muñoz C; Penacho A; Iglesias P; Guzmán AL; Abreu C; Maldonado A; Delgado M; Martín LS; Puigdevall V; Romero E; Sagrado MG; Izaola O; Conde R;
    Med Clin (Barc); 2011 Jul; 137(5):199-203. PubMed ID: 21296365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
    Manco M; Marcellini M; Devito R; Comparcola D; Sartorelli MR; Nobili V
    Int J Obes (Lond); 2008 Feb; 32(2):381-7. PubMed ID: 18087267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.
    de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
    Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease.
    Pirgon O; Cekmez F; Bilgin H; Eren E; Dundar B
    Obes Res Clin Pract; 2013; 7(4):e275-83. PubMed ID: 24306155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower plasma NAMPT/visfatin levels are associated with impaired hepatic mitochondrial function in non-diabetic obese women: a potential link between obesity and non-alcoholic fatty liver disease.
    Ruiz JR; Lasa A; Simon E; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):e1-2. PubMed ID: 22227071
    [No Abstract]   [Full Text] [Related]  

  • 28. Visfatin levels in nonalcoholic fatty liver disease.
    Akbal E; Koçak E; Taş A; Yüksel E; Köklü S
    J Clin Lab Anal; 2012 Feb; 26(2):115-9. PubMed ID: 22467327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visfatin concentrations in patients with endometrial cancer.
    Nergiz Avcioglu S; Altinkaya SO; Küçük M; Yüksel H; Ömürlü IK; Yanik S
    Gynecol Endocrinol; 2015 Mar; 31(3):202-7. PubMed ID: 25377860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations.
    Ciresi A; Amato MC; Pizzolanti G; Giordano C
    Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
    Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance.
    Ozcelik F; Yuksel C; Arslan E; Genc S; Omer B; Serdar MA
    Arch Med Res; 2013 May; 44(4):273-80. PubMed ID: 23602473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
    Targher G; Bertolini L; Scala L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Oct; 22(10):1354-8. PubMed ID: 16176196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of simvastatin treatment on plasma visfatin levels in obese women.
    Petreanu M; Eleuterio N; Bosco AA; Sandrim VC
    Gynecol Endocrinol; 2014 Aug; 30(8):577-80. PubMed ID: 24819315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects.
    Hosseinzadeh-Attar MJ; Golpaie A; Janani L; Derakhshanian H
    Obes Facts; 2013; 6(2):193-202. PubMed ID: 23615494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].
    Romanowska A; Lebensztejn DM
    Pol Merkur Lekarski; 2010 Jun; 28(168):459-61. PubMed ID: 20642104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.